SCHEMBL6316394

SCHEMBL6316394

Cc1nn(-c2ccccc2)c(C)c1-c1noc(NC(=O)c2ccc(Cl)cc2)c1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 3/20 0.48
ATM Q13315 1/20 0.48
LMNA P02545 4/20 0.46
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA4 P22748 2/20 0.44
CA7 P43166 2/20 0.44
GRM5 P41594 1/20 0.43
NR3C1 P04150 2/20 0.43
WNT3A P56704 1/20 0.42
POLB P06746 2/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
HPGD P15428 1/20 0.41
NPC1 O15118 1/20 0.41
HTT P42858 1/20 0.41
TP53 P04637 2/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315832 0.91 CA1 (0.43) KMT2AMEN1ALDH1A1LMNACA1
SCHEMBL6318278 0.91 HTT (0.44) KMT2AMEN1ALDH1A1LMNAGRM5
SCHEMBL6316791 0.90 ALDH1A1 (0.46) KMT2AMEN1ALDH1A1LMNACA1
SCHEMBL6317739 0.90 LMNA (0.46) KMT2AMEN1ALDH1A1LMNAWNT3A
SCHEMBL6318286 0.89 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1LMNACA1
SCHEMBL6317167 0.89 NR3C1 (0.42) ALDH1A1LMNANR3C1WNT3APOLB
SCHEMBL27610094 0.88 MEN1 (0.44) KMT2AMEN1ALDH1A1ATMLMNA
SCHEMBL6315001 0.87 ALDH1A1 (0.44) ALDH1A1GRM5NR3C1WNT3AHPGD
SCHEMBL6315963 0.85 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1LMNAPOLB
SCHEMBL6321867 0.85 WNT3A (0.41) KMT2AMEN1ALDH1A1LMNAWNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 KMT2A 1089/4885MEN1 2789/4885ALDH1A1 4444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.